PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer.

Abstract "Cascade testing" refers to the performance of genetic counseling and testing in blood relatives of individuals who have been identified with specific genetic mutations. Testing protocols and other interventions may save lives and improve health and quality of life for these family members. Obstetrician-gynecologists should know who is eligible for cascade testing and should use all available resources to ensure that cascade testing is offered and occurs in a timely manner. Despite the clear health benefits for specific populations and individuals, obstetrician-gynecologists should be aware of the potential barriers to cascade testing and should know which options can help patients overcome those barriers. Such barriers, however, may be overcome with health care provider awareness and participation in local and state initiatives to improve implementation of cascade testing. Resources (available within federal and state agencies, professional societies, and in advocacy and community groups) are critical to the successful implementation of cascade testing. This Committee Opinion focuses specifically on cascade testing and the role of the obstetrician-gynecologist in clinical and public health efforts to increase identification of women with hereditary cancer syndromes.
PMID
Related Publications

Identifying hereditary cancer: genetic counseling and cancer risk assessment.

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.

Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.

ACOG Committee Opinion No. 727: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer.

Authors
Mayor MeshTerms

Practice Guidelines as Topic

Keywords
Journal Title obstetrics and gynecology
Publication Year Start




PMID- 29266071
OWN - NLM
STAT- MEDLINE
DCOM- 20180108
LR  - 20180108
IS  - 1873-233X (Electronic)
IS  - 0029-7844 (Linking)
VI  - 131
IP  - 1
DP  - 2018 Jan
TI  - ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known 
      Hereditary Genetic Mutations Associated With Cancer.
PG  - 194-195
LID - 10.1097/AOG.0000000000002451 [doi]
AB  - "Cascade testing" refers to the performance of genetic counseling and testing in 
      blood relatives of individuals who have been identified with specific genetic
      mutations. Testing protocols and other interventions may save lives and improve
      health and quality of life for these family members. Obstetrician-gynecologists
      should know who is eligible for cascade testing and should use all available
      resources to ensure that cascade testing is offered and occurs in a timely
      manner. Despite the clear health benefits for specific populations and
      individuals, obstetrician-gynecologists should be aware of the potential barriers
      to cascade testing and should know which options can help patients overcome those
      barriers. Such barriers, however, may be overcome with health care provider
      awareness and participation in local and state initiatives to improve
      implementation of cascade testing. Resources (available within federal and state 
      agencies, professional societies, and in advocacy and community groups) are
      critical to the successful implementation of cascade testing. This Committee
      Opinion focuses specifically on cascade testing and the role of the
      obstetrician-gynecologist in clinical and public health efforts to increase
      identification of women with hereditary cancer syndromes.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Obstet Gynecol
JT  - Obstetrics and gynecology
JID - 0401101
SB  - AIM
SB  - IM
MH  - Advisory Committees
MH  - Evidence-Based Medicine
MH  - Female
MH  - Genetic Counseling/organization & administration
MH  - Genetic Predisposition to Disease/*prevention & control
MH  - Genetic Testing/*methods
MH  - Genital Neoplasms, Female/*genetics/prevention & control
MH  - Humans
MH  - Mass Screening/methods
MH  - Mutation/genetics
MH  - Neoplastic Syndromes, Hereditary/*diagnosis/*genetics
MH  - *Practice Guidelines as Topic
MH  - Pregnancy
MH  - United States
EDAT- 2017/12/22 06:00
MHDA- 2018/01/09 06:00
CRDT- 2017/12/22 06:00
PHST- 2017/12/22 06:00 [entrez]
PHST- 2017/12/22 06:00 [pubmed]
PHST- 2018/01/09 06:00 [medline]
AID - 10.1097/AOG.0000000000002451 [doi]
AID - 00006250-201801000-00034 [pii]
PST - ppublish
SO  - Obstet Gynecol. 2018 Jan;131(1):194-195. doi: 10.1097/AOG.0000000000002451.